Volastra Therapeutics
BioTech/Drugs - New York, NY, US
Volastra Therapeutics Employees
Volastra Therapeutics Senior Management
Volastra Therapeutics Details
Volastra Therapeutics, Inc., is developing novel therapies to treat cancer. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of solid tumors. Following initial evidence that a patient's CIN status is prognostic and that CIN alters cellular and immune response mechanisms and leads to worse overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates disease to develop novel therapeutics.
Website:
volastratx.com
Employees:
20 - 49
HQ:
N/A
Location:
New York, NY, US
Revenue:
2.5 - 5 Million
Volastra Therapeutics Technologies
Email Providers
Outlook
Support and Feedback
Zendesk
Hosting
Google Cloud Hosting
Email Delivery
Amazon SES
Recruitment
Greenhouse.io